Thermo Fisher Scientific Inc (TMO)

TMO (NYSE:Health Services) EQUITY
$172.57
neg -0.32
-0.19%
Today's Range: 172.15 - 174.36 | TMO Avg Daily Volume: 1,357,400
Last Update: 08/18/17 - 4:02 PM EDT
Volume: 1,182,474
YTD Performance: 22.53%
Open: $172.81
Previous Close: $172.89
52 Week Range: $139.07 - $182.87
Oustanding Shares: 400,207,222
Market Cap: 70,212,355,028
6-Month Chart
TheStreet Ratings Grade for TMO
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 11 12 11
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.18 1.17 1.15 1.17
Latest Dividend: 0.15
Latest Dividend Yield: 0.34%
Dividend Ex-Date: 09/14/17
Price Earnings Ratio: 30.51
Price Earnings Comparisons:
TMO Sector Avg. S&P 500
30.51 30.60 36.20
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.12% 11.78% 42.24%
GROWTH 12 Mo 3 Yr CAGR
Revenue 7.70 0.40 0.12
Net Income 2.30 0.60 0.16
EPS 3.50 0.50 0.13
Earnings for TMO:
EBITDA 4.40B
Revenue 18.27B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $2.24 $2.62 $9.24 $10.24
Number of Analysts 10 8 11 9
High Estimate $2.28 $2.66 $9.28 $10.81
Low Estimate $2.20 $2.59 $9.21 $9.85
Prior Year $2.03 $2.41 $8.27 $9.24
Growth Rate (Year over Year) 10.34% 8.82% 11.69% 10.90%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Thermo Fisher and McCormick deals show the true colors of stocks.
Update
May 19, 2017 | 9:17 AM EDT
Thermo Fisher stock coverage was initiated at Cantor Fitzgerald with an "Overweight" rating and a $194 price target.
The stock could reach $200.
It's a wonder to me how split this market really is.
Value stocks will extend their outperformance over growth stocks that began last year.
Thermo Fisher Scientific and IHS Markit are both breaking out of tight patterns.
Bearish
Dec 12, 2016 | 7:35 AM EST
TMO was removed from the Conviction Buy list, according to Goldman Sachs. $168 price target. Company lacks near-term catalysts.
Approach with caution.
Charts showing up or down trends in the past week.
We strongly recommend members avoid any temptation to trade around political events.

Columnist Conversations

Foot Locker's (FL) less than expected quarterly earnings set off a round of selling the entire athletic appare...
View Chart »  View in New Window » Gold has met the first upside target off the last setup zon...
View Chart »  View in New Window »
View Chart »  View in New Window »

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.